written reports, including local media accounts, professional medical papers and internal emails were also examined.
.
fremanezumab has completed phase iii trials and is under review by the fda to prevent migraine and
.
.
.
one downside to existing drugs that prevent migraine is they can cause unpleasant side effects like
.#1 in news, talk, and sports in los angeles and orange county
.
sponsored by an innovative medicines canada company
.
"the big unanswered question is concerns over safety in pregnancy," she says. cgrp levels are lower than normal in pregnant women who have
.
.